ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,725Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 1269

$609K Total Retail Price of All Prescriptions

Rank: 87 out of 1269

306 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 306 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 306 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 9,429 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
PRAVASTATIN SODIUM 360 307 1 11
CITALOPRAM HBR 322 307 2 21
LISINOPRIL 288 258 3 1
FUROSEMIDE 266 256 4 5
OMEPRAZOLE 260 229 5 8
LEVOTHYROXINE SODIUM 253 236 6 4
AMLODIPINE BESYLATE 250 208 7 2
METOPROLOL TARTRATE 213 184 8 6
QUETIAPINE FUMARATE 212 202 9 53
POTASSIUM CHLORIDE 189 166 10 26
FENTANYL 186 180 S2 11 105
METOPROLOL SUCCINATE 185 158 12 13
TRAMADOL HCL 183 162 13 16
DONEPEZIL HCL 180 178 14 22
SIMVASTATIN 176 166 15 3
JANTOVEN 162 144 16 52
CLONIDINE HCL 151 141 17 51
MELOXICAM 145 117 18 68
GABAPENTIN 140 102 19 17
NAMENDA 131 131 20 38
EXELON 125 114 21 142
CARVEDILOL 125 118 21 29
SERTRALINE HCL 119 100 23 23
MIRTAZAPINE 119 106 23 24
TRAZODONE HCL 111 97 25 36
CARBIDOPA-LEVODOPA 100 99 26 78
LANTUS 91 82 27 39
PREDNISONE 87 80 28 45
ATENOLOL 86 86 29 14
LOSARTAN POTASSIUM 85 79 30 15
LOVASTATIN 80 77 31 30
ATORVASTATIN CALCIUM 79 55 32 7
CLOPIDOGREL 76 74 33 32
DIVALPROEX SODIUM 75 75 34 54
DIGOXIN 72 68 35 62
ISOSORBIDE MONONITRATE ER 69 59 36 63
HEPARIN SODIUM 68 49 37 132
ALENDRONATE SODIUM 67 60 38 28
SYMBICORT 67 55 38 173
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 51 40 33
KLOR-CON M20 65 56 41 60
SEROQUEL 65 60 41 104
LOSARTAN-HYDROCHLOROTHIAZIDE 64 45 43 59
HYDRALAZINE HCL 63 59 44 48
HYDROCODONE-ACETAMINOPHEN 63 60 S3 44 20
DIOVAN 60 60 46 35
GLIMEPIRIDE 58 48 47 57
IPRATROPIUM-ALBUTEROL 57 57 48 86
HYDROCHLOROTHIAZIDE 57 54 48 10
CIPROFLOXACIN HCL 57 48 48 66
WARFARIN SODIUM 56 46 51 12
METFORMIN HCL 54 36 52 9
FAMOTIDINE 54 41 52 85
POLYETHYLENE GLYCOL 3350 53 52 54 50
NOVOLOG 53 48 54 82
PLAVIX 52 51 56 47
FLUTICASONE PROPIONATE 51 36 57 40
PROAIR HFA 51 34 57 61
SPIRIVA 51 37 57 64
PAROXETINE HCL 50 36 60 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.